For the Inventor, By the Inventor

Enter assignee name

Hellerup, Denmark

Ascendis Pharma Endocrinology Division A/s

USPTO Granted Patents = 9

CIPO Patents = 14

EPO Patents = 9

Trademarks = 14

Forward Citations = 25

Loading Chart...

Loading Chart...

51 inventors (with patents filed for the assignee):

Harald Rau (7 out of 56 patents)

Thomas Wegge (7 out of 38 patents)

Susanne Kindermann (6 out of 7 patents)

4. Kennett Sprogøe (4 out of 28 patents)

5. Grethe Nørskov Rasmussen (4 out of 6 patents)

6. Ulrich Hersel (3 out of 40 patents)

7. Grethe Norskov Rasmussen (3 out of 25 patents)

8. Torben Leßmann (2 out of 2 patents)

9. Steen Jensen (2 out of 3 patents)

10. Thomas Kurpiers (2 out of 2 patents)

11. Henrik Egesborg (1 out of 13 patents)

12. Evelyn Exner (1 out of 2 patents)

13. Alina Hermann (1 out of 2 patents)

14. Nina Schubert (1 out of 2 patents)

15. Joachim Zettler (1 out of 13 patents)

9 patents: Sort by Forward Citations

1. 12303553 - Long-acting growth hormone dosage forms with superior efficacy to daily somatropin (2025-05-20),

2. 12274737 - PEGylated recombinant human growth hormone compounds (2025-04-14),

3. 12226457 - Dry growth hormone composition transiently linked to a polymer carrier (2025-02-18),

4. 12133883 - Polymeric hGH prodrugs (2024-11-05),

5. 12016903 - Long-acting growth hormone treatment (2024-06-25),

6. 10960053 - PEGylated recombinant human growth hormone compounds (2021-03-30),

7. 10682395 - Dry growth hormone composition transiently linked to a polymer carrier (2020-06-16),

8. 10098930 - PEGylated Recombinant Human Growth Hormone Compounds (2018-10-16),

9. 9919033 - Dry growth hormone composition transiently linked to a polymer carrier (2018-03-20),

Ascendis Pharma Endocrinology Division A/S is a biopharmaceutical company dedicated to developing innovative therapies for rare endocrine diseases. Their focus is on developing long-acting prodrug therapies that provide sustained release and improved patient outcomes. With a strong pipeline of potential treatments in development, Ascendis Pharma is committed to improving the lives of patients with rare endocrine disorders.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

9 Patents

#5 in Hellerup

#294 in Denmark

Hellerup, Denmark

Ascendis Pharma Endocrinology Division A/s

Forward Citations = 25

51 inventors:

Harald Rau (7 out of 56 patents)

Thomas Wegge (7 out of 38 patents)

Susanne Kindermann (6 out of 7 patents)

4. Kennett Sprogøe (4 out of 28 patents)

5. Grethe Nørskov Rasmussen (4 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…